Medical & Biological Laboratories Co., Ltd. (JASDAQ:4557) agreed to acquire remaining 91.3% stake in ACTGen, Inc. from Toshieki Kajikawa and other shareholders for ¥0.52 million in stock on January 22, 2013. Medical & Biological Laboratories Co., Ltd. will allocate 0.02 common shares in exchange for every common share of ACTGen. Medical & Biological Laboratories is acquiring 0.08 million shares of ACTGen, Inc. representing 91.3% stake. Toshieki Kajikawa is selling its 90.3% stake. The transaction has been resolved by Board of Directors of Medical & Biological Laboratories Co., Ltd. The transaction is still subject to approval by shareholders of ACTGen, Inc. which is due on January 31, 2013. The transaction is expected to close by March 1, 2013.

Medical & Biological Laboratories Co., Ltd. (JASDAQ:4557) cancelled the acquisition of remaining 91.3% stake in ACTGen, Inc. from Toshieki Kajikawa and other shareholders in stock on January 22, 2014.